Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Nitric Oxide via Cardiopulmonary Bypass on Ventilator-Free Days in Young Children Undergoing Congenital Heart Disease Surgery: The NITRIC Randomized Clinical Trial.
Schlapbach LJ, Gibbons KS, Horton SB, Johnson K, Long DA, Buckley DHF, Erickson S, Festa M, d'Udekem Y, Alphonso N, Winlaw DS, Delzoppo C, van Loon K, Jones M, Young PJ, Butt W, Schibler A; NITRIC Study Group, the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG), and the ANZICS Paediatric Study Group (PSG). Schlapbach LJ, et al. Among authors: jones m. JAMA. 2022 Jul 5;328(1):38-47. doi: 10.1001/jama.2022.9376. JAMA. 2022. PMID: 35759691 Free PMC article. Clinical Trial.
A Randomized Trial of High-Flow Oxygen Therapy in Infants with Bronchiolitis.
Franklin D, Babl FE, Schlapbach LJ, Oakley E, Craig S, Neutze J, Furyk J, Fraser JF, Jones M, Whitty JA, Dalziel SR, Schibler A. Franklin D, et al. Among authors: jones m. N Engl J Med. 2018 Mar 22;378(12):1121-1131. doi: 10.1056/NEJMoa1714855. N Engl J Med. 2018. PMID: 29562151 Free article. Clinical Trial.
Study protocol: NITric oxide during cardiopulmonary bypass to improve Recovery in Infants with Congenital heart defects (NITRIC trial): a randomised controlled trial.
Schlapbach LJ, Horton SB, Long DA, Beca J, Erickson S, Festa M, d'Udekem Y, Alphonso N, Winlaw D, Johnson K, Delzoppo C, van Loon K, Gannon B, Fooken J, Blumenthal A, Young P, Jones M, Butt W, Schibler A; NITRIC Study Group, the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG), the Paediatric Critical Care Research group (PCCRG) and the ANZICS Paediatric Study Group (PSG). Schlapbach LJ, et al. Among authors: jones m. BMJ Open. 2019 Aug 15;9(8):e026664. doi: 10.1136/bmjopen-2018-026664. BMJ Open. 2019. PMID: 31420383 Free PMC article.
Enteral hydration in high-flow therapy for infants with bronchiolitis: Secondary analysis of a randomised trial.
Babl FE, Franklin D, Schlapbach LJ, Oakley E, Dalziel S, Whitty JA, Neutze J, Furyk J, Craig S, Fraser JF, Jones M, Schibler A; Paediatric Research in Emergency Departments International Collaborative and Pediatric Critical Care Research Group. Babl FE, et al. Among authors: jones m. J Paediatr Child Health. 2020 Jun;56(6):950-955. doi: 10.1111/jpc.14799. Epub 2020 Feb 11. J Paediatr Child Health. 2020. PMID: 32043304 Clinical Trial.
Effect of Early High-Flow Nasal Oxygen vs Standard Oxygen Therapy on Length of Hospital Stay in Hospitalized Children With Acute Hypoxemic Respiratory Failure: The PARIS-2 Randomized Clinical Trial.
Franklin D, Babl FE, George S, Oakley E, Borland ML, Neutze J, Acworth J, Craig S, Jones M, Gannon B, Shellshear D, McCay H, Wallace A, Hoeppner T, Wildman M, Mattes J, Pham TMT, Miller L, Williams A, O'Brien S, Lawrence S, Bonisch M, Gibbons K, Moloney S, Waugh J, Hobbins S, Grew S, Fahy R, Dalziel SR, Schibler A. Franklin D, et al. Among authors: jones m. JAMA. 2023 Jan 17;329(3):224-234. doi: 10.1001/jama.2022.21805. JAMA. 2023. PMID: 36648469 Free PMC article. Clinical Trial.
High-flow nasal oxygen for children's airway surgery to reduce hypoxaemic events: a randomised controlled trial.
Humphreys S, von Ungern-Sternberg BS, Taverner F, Davidson A, Skowno J, Hallett B, Sommerfield D, Hauser N, Williams T, Spall S, Pham T, Atkins T, Jones M, King E, Burgoyne L, Stephens P, Vijayasekaran S, Slee N, Burns H, Franklin D, Hough J, Schibler A. Humphreys S, et al. Among authors: jones m. Lancet Respir Med. 2024 Jul;12(7):535-543. doi: 10.1016/S2213-2600(24)00115-2. Epub 2024 May 21. Lancet Respir Med. 2024. PMID: 38788748 Clinical Trial.
Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial.
Hockham C, Kotwal S, Wilcox A, Bassi A, McGree J, Pollock C, Burrell LM, Bathla N, Kunigari M, Rathore V, John M, Lin E, Jenkins C, Ritchie A, McLachlan A, Snelling T, Jones M, Jha V, Jardine M; CLARITY Investigators. Hockham C, et al. Among authors: jones m. Trials. 2021 Aug 28;22(1):573. doi: 10.1186/s13063-021-05521-0. Trials. 2021. PMID: 34454580 Free PMC article.
Immunogenicity of a Third Scheduled Dose of Rotarix in Australian Indigenous Infants: A Phase IV, Double-blind, Randomized, Placebo-Controlled Clinical Trial.
Middleton BF, Danchin M, Jones MA, Leach AJ, Cunliffe N, Kirkwood CD, Carapetis J, Gallagher S, Kirkham LA, Granland C, McNeal M, Marsh JA, Waddington CS, Snelling TL. Middleton BF, et al. Among authors: jones ma. J Infect Dis. 2022 Nov 1;226(9):1537-1544. doi: 10.1093/infdis/jiac038. J Infect Dis. 2022. PMID: 35134951 Free PMC article. Clinical Trial.
Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial.
Jardine MJ, Kotwal SS, Bassi A, Hockham C, Jones M, Wilcox A, Pollock C, Burrell LM, McGree J, Rathore V, Jenkins CR, Gupta L, Ritchie A, Bangi A, D'Cruz S, McLachlan AJ, Finfer S, Cummins MM, Snelling T, Jha V; CLARITY trial investigators. Jardine MJ, et al. Among authors: jones m. BMJ. 2022 Nov 16;379:e072175. doi: 10.1136/bmj-2022-072175. BMJ. 2022. PMID: 36384746 Free PMC article. Clinical Trial.
14,282 results
You have reached the last available page of results. Please see the User Guide for more information.